Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,765.99
(
0.35%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dewophile

Send PM Follow Ignore
Followers 49
Posts 5519
Boards Moderated 0
Alias Born 07/19/2006

dewophile

Re: anotherbiotechguy post# 5458

Friday, 11/02/2007 10:34:01 AM

Friday, November 02, 2007 10:34:01 AM

Post# of 19309
agreed
as far as I know there is no IP barrier to adding an N-glycosylation signal sequence to the construct (I perused Amgen's patent years ago and it was fairly narrow and specific to epo)
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today